Basis: Trailing twelve months (TTM), to the latest fiscal quarter end. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the return on invested capital (ROIC) high or low?
The return on invested capital (ROIC) of -107.08% is 45% above its 5-year average of -195.71%, near the high end of its 5-year range (-1615.81%–-38.77%).
As of the fiscal period ended Tuesday, June 30, 2026. 83.56% above its 12-month average of -651.22%.
Trailing-twelve-month return on invested capital at each fiscal quarter end; no daily interpolation. Q2 FY2026 (2026-06-30): -107.08%.
RETURN ON INVESTED CAPITAL (ROIC)
-107.08%
RETURN ON INVESTED CAPITAL (ROIC) AVG TTM
-651.22%
RETURN ON INVESTED CAPITAL (ROIC) AVG 3Y
-637.01%
RETURN ON INVESTED CAPITAL (ROIC) AVG 5Y
-195.71%
RETURN ON INVESTED CAPITAL (ROIC) AVG 10Y
-214.99%
RETURN ON INVESTED CAPITAL (ROIC) AVG 15Y
N/A
RETURN ON INVESTED CAPITAL (ROIC) AVG 20Y
N/A
CURRENT VS TTM AVG
+83.56%
CURRENT VS 3Y AVG
+83.19%
CURRENT VS 5Y AVG
+45.29%
CURRENT VS 10Y AVG
+50.19%
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-35.64%
median of 838 covered companies
CURRENT VS SECTOR MEDIAN
-200.41%
vs the sector median at left
Genprex, Inc.
Market Cap
$1.35M
Return on Invested Capital (ROIC)
-107.08%
TTM Avg
-651.22%
3Y Avg
-637.01%
5Y Avg
-195.71%
Market Cap
$1.37M
Return on Invested Capital (ROIC)
-32.53%
TTM Avg
-171.99%
3Y Avg
-201.88%
5Y Avg
-239.63%
Market Cap
$1.34M
Return on Invested Capital (ROIC)
-219.36%
TTM Avg
-214.97%
3Y Avg
-160.97%
5Y Avg
-133.06%
Market Cap
$1.35M
Return on Invested Capital (ROIC)
-709.40%
TTM Avg
-164.13%
3Y Avg
-164.13%
5Y Avg
-164.13%
Market Cap
$1.43M
Return on Invested Capital (ROIC)
-28.43%
TTM Avg
-37.81%
3Y Avg
-267.17%
5Y Avg
-197.37%
Market Cap
$1.44M
Return on Invested Capital (ROIC)
-41.80%
TTM Avg
-42.68%
3Y Avg
-41.38%
5Y Avg
-63.25%
Market Cap
$1.47M
Return on Invested Capital (ROIC)
-567.17%
TTM Avg
-332.51%
3Y Avg
-201.53%
5Y Avg
-141.19%
Market Cap
$1.46M
Return on Invested Capital (ROIC)
N/A
TTM Avg
-48.91%
3Y Avg
-66.07%
5Y Avg
-87.70%
Market Cap
$1.49M
Return on Invested Capital (ROIC)
-163.98%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
| NAME | MARKET CAP | RETURN ON INVESTED CAPITAL (ROIC) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Genprex, Inc. (GNPX) | $1.35M | -107.08% | -651.22% | -637.01% | -195.71% |
| NewcelX Ltd. (NCEL)vs › | $1.37M | -32.53% | -171.99% | -201.88% | -239.63% |
| Artelo Biosciences, Inc. (ARTL)vs › | $1.34M | -219.36% | -214.97% | -160.97% | -133.06% |
| Jupiter Neurosciences, Inc. (JUNS)vs › | $1.35M | -709.40% | -164.13% | -164.13% | -164.13% |
| INVO Fertility, Inc. (IVF)vs › | $1.43M | -28.43% | -37.81% | -267.17% | -197.37% |
| NEXGEL, Inc. (NXGL)vs › | $1.44M | -41.80% | -42.68% | -41.38% | -63.25% |
| Curis, Inc. (CRIS)vs › | $1.47M | -567.17% | -332.51% | -201.53% | -141.19% |
| PMGC Holdings Inc. (ELAB)vs › | $1.46M | N/A | -48.91% | -66.07% | -87.70% |
| Lakewood-Amedex Biotherapeutics, Inc. (LABT)vs › | $1.49M | -163.98% | N/A | N/A | N/A |
| Propanc Biopharma, Inc. (PPCB)vs › | $1.14M | -183.49% | -279.63% | -279.63% | -279.63% |
ROIC
-107.1%
ROE
-111.5%
ROIC = NOPAT / Invested Capital, where NOPAT = Operating Income × (1 − effective tax rate) and Invested Capital = Total Assets − (Current Liabilities − Short-Term Debt)
Return on invested capital measures the after-tax operating return a company earns on the capital invested in the business. TGMCharts computes it from reported statements: trailing-twelve-month operating income after tax, over invested capital at the latest balance sheet — total assets less the non-interest-bearing current liabilities (payables, accruals, deferred revenue) that fund them; short-term debt stays in the capital base. The tax rate is the period's own effective rate (income tax ÷ pretax income), capped at 45%; when pretax income is zero or negative, or the tax line is a net benefit, no tax is deducted — the operating figure is shown untaxed rather than adjusted by an assumed rate. Not shown for banks, insurers or funds.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | RETURN ON INVESTED CAPITAL (ROIC) |
|---|---|
| 2026-06-30 | -107.08% |
| 2026-03-31 | -94.62% |
| 2025-12-31 | -194.32% |
| 2025-09-30 | -1615.81% |
| 2025-06-30 | -1244.27% |
| 2025-03-31 | -495.02% |
| 2024-12-31 | -1306.92% |
| 2024-09-30 | -1370.91% |
| 2024-06-30 | -604.94% |
| 2024-03-31 | -317.54% |
| 2023-12-31 | -418.98% |
| 2023-09-30 | -259.30% |
| 2023-06-30 | -251.37% |
| 2023-03-31 | -151.62% |
| 2022-12-31 | -108.07% |
| 2022-09-30 | -83.43% |
| 2022-06-30 | -62.33% |
| 2022-03-31 | -49.75% |
| 2021-12-31 | -47.49% |
| 2021-09-30 | -42.39% |
| 2021-06-30 | -38.77% |
| 2021-03-31 | -37.44% |
| 2020-12-31 | -58.10% |
| 2020-09-30 | -65.98% |
| 2020-06-30 | -60.23% |
| 2020-03-31 | -58.84% |
| 2019-12-31 | -353.32% |
| 2019-09-30 | -331.31% |
| 2019-06-30 | -216.25% |
| 2019-03-31 | -191.13% |
| 2018-12-31 | -139.21% |
| 2018-09-30 | -91.42% |
| 2018-06-30 | -64.36% |
| 2018-03-31 | -1368.17% |
| 2017-12-31 | -772.87% |
| 2017-09-30 | -418.43% |
| 2017-06-30 | -457.54% |
| 2017-03-31 | -411.92% |
| 2016-12-31 | -254.31% |
